You are viewing an Email identified as a Scam, It has the Subject "Investor Insight" and it was received in one of Scamdex's honeypot email accounts on Wed, 23 Jul 2008 16:16:01 -0700 and has been classified as a Advance Fee Fraud/419 Scam. The sender was "Roslyn Hammer" <MargerymandamusOleary@yahoo.com>, although that address was probably spoofed. It is recommended that you do not attempt to contact any persons or organizations referenced in this email, as you will expose yourself to scammers and, at the very least, you will be added to their email address lists for spam purposes.
Global Agri-Med Technologies, Inc
This new bio tech IPO has huge potential with their new product BreastAlert
BreastAlert is a new device that simply, easily and accurately screens for the presence of heat producing breast abnormalities including breast cancer. We at BreastAlert are committed to providing women with the ability to take charge of their 'breast cancer screening program' with a painless, easy-to-read device for screening for this dreaded disease.
Composed of two pads with foil on one side, the device produces an easy-to-read record of the temperature distribution of the two breasts and provides a simple method for computing the results.
Breast cancer remains the leading cause of cancer in women and with an alternative to painful and expensive mamogram available in BreastAlert this company has a potential to skyrocket in coming weeks
price : $0.63 ( up 2 days in a row)
In coming weeks Global Agri-Med is planning to announce the terms of distribution agreement with wholesale company PIF Medical of Nottingham
This is the recent Letter to shareholders from the CEO of Global Agri-Med Technologies
July 21, 2008
Shareholders of Global Agri-Med Technologies, Inc.
RE: Recent Devlopments
After many years of trying we have finally commenced trading in the common shares of Global Agri-Med Technologies, Inc. under the symbol GAGO. More importantly we have reconfirmed the interest of PIF Medical of Nottingham in acting as our wholesaler in the United Kingdom. Over the next few weeks we expect to formalize the terms of that distribution arrangement.
We are also actively negotiating an amendment to our distribution agreement with Scantek Medical and I will keep you apprised of the results of that renegotiation.
Upon conclusion of the distribution arrangement and the distribution agreement we expect to place our first order for BreastAlert with an eye toward launching in England during breast cancer awareness month in October.
Get in GAGO and ride gains as this small cap goes Mega